Order results by:
Issue | Title | |
Vol 15, No 3 (2023) | Vitamin B12 deficiency and Parkinson’s disease | Abstract similar documents |
Z. A. Zalyalova, E. V. Ekusheva | ||
"... , are more often associated with vitamin B12 deficiency. Several reasons for this association and mechanisms ..." | ||
Vol 13, No 4 (2021) | Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety | Abstract similar documents |
E. V. Shikh, Zh. M. Sizova, M. O. Astaeva | ||
"... The prevalence of vitamin В12 deficiency is about 3—16% in the general population, while in older ..." | ||
Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
Natalia Vladimirovna Fedorova | ||
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..." | ||
Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
A. V. Obukhova | ||
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
Vol 8, No 3 (2016) | Longitudinally extensive transverse myelitis associated with intrathecal synthesis of oligoclonal immunoglobulin G and with vitamin B12 deficiency | Abstract similar documents |
V. S. Krasnov, A. S. Bedenko, N. A. Totolyan, A. A. Skoromets | ||
"... : inflammation and thrombogenesis. In this case vitamin B12 deficiency could predispose to the initiation ..." | ||
Vol 13, No 1 (2021) | Nociception: the roles of vitamin D | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, M. V. Putilina, I. S. Sardaryan, L. E. Fedotova, O. A. Limanova | ||
"... on on the relationships between the effects of vitamin and nociception (including the impact of vitamin D deficiency ..." | ||
Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
"... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. Consequently, there has ..." | ||
Vol 4, No 4 (2012) | Use of vitamin B 1 preparations with different solubility in fats/oils and aqueous media: Clinical and pharmacological aspects | Abstract similar documents |
Galina Vladislavovna Ramenskaya, O A Petukhova, V V Smirnov | ||
"... An abundance of drugs to prevent and treat vitamin B 1 deficiency-induced ..." | ||
Vol 2, No 2 (2010) | Correction of cholinergic deficiency in patients with vascular dementia | Abstract similar documents |
O. I. Mokhova | ||
Vol 16, No 6 (2024) | Vitamins and other nutrients that support nitric oxide homeostasis and counteract the development of endotheliopathy | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, L. A. Mayorova | ||
"... . The correction of deficiencies in these vitamins (group B, A, C, E, D3), magnesium and calcium is an important ..." | ||
Vol 11, No 3 (2019) | Neurological complications of alcoholic disease and ways of their correction | Abstract similar documents |
A. Yu. Emelyanova, O. E. Zinovyeva, S. R. Fedoseev, E. V. Misyuryaeva | ||
"... mechanisms of the main (chronic toxic and acute/subacute) forms of APN associated with thiamine deficiency ..." | ||
Vol 13, No 2 (2021) | Central pontine myelinolysis in the presence of SARS-CoV-2 infection (clinical observations) | Abstract similar documents |
O. N. Voskresenskaya, A. A. Kovalenko, E. B. Nadbitova, V. V. Grinyuk, A. V. Klimanov, Yu. M. Shor | ||
Vol 1, No 2 (2009) | THE PROBLEMS OF THE PATHOGENESIS AND TREATMENT OF ALCOHOLIC POLYNEUROPATHY | Abstract similar documents |
O. E. Zinov'eva, O. I. Angel'cheva | ||
"... with deficiency of B-group vitamins, including thiamine, are discussed. The use of B-group vitamins and α-lipoic ..." | ||
Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..." | ||
Vol 6, No 1 (2014) | Attention deficit hyperactivity disorder in children | Abstract similar documents |
O.E. Zinov'eva, E.G. Rogovina, E.A. Tyrinova | ||
"... , hyperactivity and impulsivity, as well as symptoms of staticolocomotory deficiency. The pathogenesis, diagnosis ..." | ||
Vol 3, No 1 (2011) | Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease | Abstract similar documents |
I. G. Tishkova, I. S. Preobrazhenskaya | ||
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..." | ||
Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
M. R. Nodel, N. N. Yakhno | ||
"... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..." | ||
Vol 13, No 2 (2021) | Malnutrition and perspectives of nutritional therapy for mental disorders | Abstract similar documents |
D. V. Romanov, K. Yu. Dmitrenko | ||
"... Metabolic disorders associated with nutritional deficiency/imbalance are common in various ..." | ||
Vol 8, No 4 (2016) | HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE | Abstract similar documents |
M. R. Nodel | ||
"... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..." | ||
Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
A V Nikitina, Natalia Vladimirovna Fedorova | ||
"... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..." | ||
Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
"... in the early stages of Parkinson’s disease (PD) and considers the hypothesis of the presence of body-first ..." | ||
Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
M. R. Sapronova, N. A. Shnaider | ||
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..." | ||
Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
Marina Romanovna Nodel | ||
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..." | ||
Vol 16, No 3 (2024) | Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries | Abstract similar documents |
E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova | ||
"... The review addresses an approach to the treatment of early stages of Parkinson's disease (PD ..." | ||
Vol 9, No 4 (2017) | Neuropsychological pattern of Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova | ||
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..." | ||
Vol 9, No 1 (2017) | The genetic basis of Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova | ||
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..." | ||
Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
M. R. Nodel' | ||
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..." | ||
Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
M. R. Nodel | ||
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..." | ||
Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
M. R. Nodel | ||
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..." | ||
Vol 17, No 3 (2025) | Parkinson's disease and migraine | Abstract similar documents |
Z. A. Zalyalova, E. A. Katunina, D. V. Pokhabov | ||
"... Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Migraine ..." | ||
Vol 14, No 2 (2022) | Effect of hypovitaminosis D on the characteristics of chronic tension-type headache in women | Abstract similar documents |
A. A. Koloskova, O. V. Vorobyeva | ||
"... of the listed parameters, the values in vitamin D deficiency were higher than in its insufficiency or normal ..." | ||
Online-first | Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor | Abstract similar documents |
A. V. Kudrevatykh, I. V. Miliukhina | ||
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..." | ||
Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
I. V. Milyukhina | ||
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..." | ||
Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
M. R. Nodel | ||
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..." | ||
Vol 12, No 3 (2020) | Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism | Abstract PDF (Eng) similar documents |
I. V. Smagina, K. V. Lunev, S. A. Elchaninova | ||
"... ). Conclusion. Vitamin D deficiency is more common in patients with MS than in those without this disease ..." | ||
Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
M. R. Nodel, G. V. Kovrov | ||
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..." | ||
Vol 6, No 4 (2014) | Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease | Abstract similar documents |
V. L. Golubev, A. B. Kamakinova | ||
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..." | ||
Vol 4, No 1 (2012) | Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy | Abstract similar documents |
Marina Romanovna Nodel | ||
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..." | ||
Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
S N Illarioshkin | ||
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..." | ||
Vol 17, No 3 (2025) | Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease | Abstract similar documents |
A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov | ||
"... Most patients with Parkinson’s disease (PD) experience autonomic cardiovascular dysfunction ..." | ||
Vol 2, No 3 (2010) | Treatment of parkinson's disease at a young age | Abstract similar documents |
D. V. Artemyev | ||
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..." | ||
Vol 1, No 2 (2009) | NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE | Abstract similar documents |
M. R. Nodel', N. N. Yakhno | ||
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..." | ||
Vol 5, No 2 (2013) | Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures | Abstract similar documents |
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov | ||
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..." | ||
Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
Denis Valeryevich Zakharov, V A Mikhailov | ||
"... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..." | ||
Vol 5, No 2 (2013) | The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms | Abstract similar documents |
E N Gubanova, Natalia Vladimirovna Fedorova | ||
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..." | ||
Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
Oleg Semenovich Levin, V K Datiyeva | ||
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..." | ||
Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
I. V. Miliukhina | ||
"... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..." | ||
Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..." | ||
Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
E. V. Yakovenko, F. A. Abbasov | ||
"... Mental and cognitive impairments are common non-motor symptoms of Parkinson's disease (PD), which ..." | ||
Vol 15, No 1 (2023) | The gut microbiome as a factor in the development of Parkinson's disease | Abstract similar documents |
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov | ||
"... Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive death ..." | ||
Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
"... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..." | ||
Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
Marina Romanovna Nodel | ||
"... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..." | ||
Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
"... The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads ..." | ||
Vol 16, No 1 (2024) | On the antitumour effects of B vitamins | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, M. V. Filimonova, D. E. Frolova | ||
"... In periodicals, vitamins and vitamin-mineral complexes (VMCs) are “accused” of having allegedly ..." | ||
Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
"... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..." | ||
Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
"... the frequency-amplitude characteristics in the correction of tremulous hyperkinesis in Parkinson's disease (PD ..." | ||
Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
"... effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine ..." | ||
Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
"... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..." | ||
Vol 13, No 3 (2021) | Differential diagnosis of convulsions in the structure of dissociative (conversion motor) disorder and chronic postoperative hypoparathyroidism: case report and literature review | Abstract similar documents |
Yu. A. Krupinova, T. A. Zelenkova-Zakharchuk, E. V. Kovaleva, Sh. T. Ashurbekova, A. K. Eremkina, N. G. Mokrysheva | ||
"... as a result of the absence or deficiency of parathyroid hormone. The severity of the condition of patients ..." | ||
Vol 11, No 3 (2019) | The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor | Abstract similar documents |
A. V. Kudrevatykh, I. V. Miliukhina | ||
"... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..." | ||
Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
N. V. Trofimova, I. S. Preobrazhenskaya | ||
Vol 7, No 4 (2015) | Acute cerebellar ataxia in a young woman: Wernicke’s encephalopathy? | Abstract similar documents |
S. G. Dolgova, A. S. Kotov, Yu. V. Matyuk, M. N. Borisova, M. V. Panteleeva, A. V. Shatalin | ||
"... deficiency. According to the data of autopsy studies, the prevalence of WE in the general population varies ..." | ||
Vol 7, No 2 (2015) | Neuromuscular disorders in chronic alcohol intoxication | Abstract similar documents |
A. Yu. Emelyanova, O. E. Zinovyeva, N. D. Samkhaeva, N. S. Shcheglova | ||
"... neuropathy, the basis for the pathogenesis of which is B group vitamins, predominantly thiamine, deficiency ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Neurocognitive deficit in patients with schizophrenia | Abstract similar documents |
A. B. Shmukler, I. Ya. Gurovich, Yu. S. Zaitseva | ||
"... Нейрокогнитивный дефицит рассматривается как третья ключевая группа симптомов при шизофрении. На ..." | ||
Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..." | ||
Vol 11, No 3 (2019) | The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases | Abstract similar documents |
I. V. Miliukhina | ||
"... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..." | ||
Vol 3, No 3 (2011) | Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) | Abstract similar documents |
M. R. Nodel | ||
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..." | ||
Vol 12, No 2 (2020) | «Masks» of alcoholic polyneuropathy | Abstract similar documents |
N. V. Pizova | ||
"... describes main risk factors for alcoholic PNP, such as malnutrition, thiamine deficiency, direct alcohol ..." | ||
Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..." | ||
1 - 70 of 224 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)